216 related articles for article (PubMed ID: 36090057)
1. The protein kinase CK1: Inhibition, activation, and possible allosteric modulation.
Sunkari YK; Meijer L; Flajolet M
Front Mol Biosci; 2022; 9():916232. PubMed ID: 36090057
[TBL] [Abstract][Full Text] [Related]
2. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
Li SS; Dong YH; Liu ZP
Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
[TBL] [Abstract][Full Text] [Related]
4. Casein kinase I gamma subfamily. Molecular cloning, expression, and characterization of three mammalian isoforms and complementation of defects in the Saccharomyces cerevisiae YCK genes.
Zhai L; Graves PR; Robinson LC; Italiano M; Culbertson MR; Rowles J; Cobb MH; DePaoli-Roach AA; Roach PJ
J Biol Chem; 1995 May; 270(21):12717-24. PubMed ID: 7759525
[TBL] [Abstract][Full Text] [Related]
5. The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development.
Knippschild U; Wolff S; Giamas G; Brockschmidt C; Wittau M; Würl PU; Eismann T; Stöter M
Onkologie; 2005 Oct; 28(10):508-14. PubMed ID: 16186692
[TBL] [Abstract][Full Text] [Related]
6. Targeting casein kinase 1 for cancer therapy: current strategies and future perspectives.
Long NH; Lee SJ
Front Oncol; 2023; 13():1244775. PubMed ID: 38023245
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.
Allocco JJ; Donald R; Zhong T; Lee A; Tang YS; Hendrickson RC; Liberator P; Nare B
Int J Parasitol; 2006 Oct; 36(12):1249-59. PubMed ID: 16890941
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1.
Marin O; Meggio F; Sarno S; Andretta M; Pinna LA
Eur J Biochem; 1994 Jul; 223(2):647-53. PubMed ID: 8055935
[TBL] [Abstract][Full Text] [Related]
9. Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.
Oumata N; Bettayeb K; Ferandin Y; Demange L; Lopez-Giral A; Goddard ML; Myrianthopoulos V; Mikros E; Flajolet M; Greengard P; Meijer L; Galons H
J Med Chem; 2008 Sep; 51(17):5229-42. PubMed ID: 18698753
[TBL] [Abstract][Full Text] [Related]
10. CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders.
Baier A; Szyszka R
Front Mol Biosci; 2022; 9():916063. PubMed ID: 36275622
[TBL] [Abstract][Full Text] [Related]
11. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
[TBL] [Abstract][Full Text] [Related]
12. Achieving effective and selective CK1 inhibitors through structure modification.
Du C; Yang H; Feng F; Liu W; Chen Y; Sun H
Future Med Chem; 2021 Mar; 13(5):505-528. PubMed ID: 33438471
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.
Rachidi N; Taly JF; Durieu E; Leclercq O; Aulner N; Prina E; Pescher P; Notredame C; Meijer L; Späth GF
Antimicrob Agents Chemother; 2014; 58(3):1501-15. PubMed ID: 24366737
[TBL] [Abstract][Full Text] [Related]
14. Optimal sequences for non-phosphate-directed phosphorylation by protein kinase CK1 (casein kinase-1)--a re-evaluation.
Pulgar V; Marin O; Meggio F; Allende CC; Allende JE; Pinna LA
Eur J Biochem; 1999 Mar; 260(2):520-6. PubMed ID: 10095790
[TBL] [Abstract][Full Text] [Related]
15. Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).
Xu P; Ianes C; Gärtner F; Liu C; Burster T; Bakulev V; Rachidi N; Knippschild U; Bischof J
Gene; 2019 Oct; 715():144005. PubMed ID: 31376410
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of behavioral hypersensitivity in mouse models of inflammatory pain with two structurally different casein kinase 1 (CK1) inhibitors.
Kurihara T; Sakurai E; Toyomoto M; Kii I; Kawamoto D; Asada T; Tanabe T; Yoshimura M; Hagiwara M; Miyata A
Mol Pain; 2014 Mar; 10():17. PubMed ID: 24612480
[TBL] [Abstract][Full Text] [Related]
17. Identification, cloning, and mutational analysis of the casein kinase 1 cDNA of the malaria parasite, Plasmodium falciparum. Stage-specific expression of the gene.
Barik S; Taylor RE; Chakrabarti D
J Biol Chem; 1997 Oct; 272(42):26132-8. PubMed ID: 9334178
[TBL] [Abstract][Full Text] [Related]
18. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes.
Knippschild U; Gocht A; Wolff S; Huber N; Löhler J; Stöter M
Cell Signal; 2005 Jun; 17(6):675-89. PubMed ID: 15722192
[TBL] [Abstract][Full Text] [Related]
19. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
[TBL] [Abstract][Full Text] [Related]
20. A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection.
MacLaine NJ; Oster B; Bundgaard B; Fraser JA; Buckner C; Lazo PA; Meek DW; Höllsberg P; Hupp TR
J Biol Chem; 2008 Oct; 283(42):28563-73. PubMed ID: 18669630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
